Antihypertensive Therapy for Prehypertension: Relationship With Cardiovascular Outcomes

Ventura, Hector O.; Lavie, Carl J.
March 2011
JAMA: Journal of the American Medical Association;3/2/2011, Vol. 305 Issue 9, p940
Academic Journal
The article comments on a study which examined whether treatment with antihypertensive therapy compared to placebo would be associated with a reduction in cardiovascular morbidity and mortality in patients with a history of cerebrovascular disease (CVD) or diabetes mellitus. It points out that the study failed to determine whether lowering blood pressure levels is the reason for the improved outcomes. It notes the ambiguity of the study's implications for patients without CVD. IT recommends further research or study for those without CVD.


Related Articles

  • Efficacy and Safety of Fixed Combinations of Irbesartan/Hydrochlorothiazide in Hypertensive Women: The Inclusive Trial. Ofili, Elizabeth O.; Cable, Greg; Neutel, Joel M.; Saunders, Elijah // Journal of Women's Health (15409996);Jul/Aug2008, Vol. 17 Issue 6, p931 

    Objective: This post hoc analysis of the Irbesartan/Hydrochlorothiazide Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) trial evaluated the efficacy and safety of irbesartan/hydrochlorothiazide (HCTZ) in a diverse population of hypertensive women. Methods: INCLUSIVE was a...

  • Brain Infarction Developed in Hypertensive and Normotensive Patients During Hospitalization--Hemodynamic Factors. Sugimori, Hiroshi; Ibayashi, Setsuro; Fujii, Kenichiro; Yao, Hiroshi; Sadoshima, Seizo; Fujishima, Masatoshi // Angiology;Jun1995, Vol. 46 Issue 6, p473 

    To determine the effects of changes in blood pressure (BP) on the development of ischemic stroke, 17 patients who developed acute brain infarction during hospitalization were analyzed in relation to the vascular risk factors such as hypertension, previous stroke, diabetes mellitus, and...

  • Comparing the Safety and Tolerability of Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain (DPNP) Between Patients With and Without Historical and/or Co-Morbid Cardiovascular Conditions. Wernicke, Joachim; Prakash, Apurva; Kajdasz, Daniel; Houston, John // Diabetes;Jun2007 Supplement 1, Vol. 56, pA557 

    Diabetic patients are predisposed to hypertension and other cardiovascular (CV) conditions. Within our DPNP database, we compared the safety and tolerability of duloxetine between patients with and without historical (Hx) or co-morbid CV conditions at study entry. Data were pooled from 3...

  • Effect of spironolactone in patients with resistant arterial hypertension in relation to age and sex: Insights from the aspirant trial. Vaclavik, Jan; Sedlak, Richard; Jarkovsky, Jiri; Kocianova, Eva; Taborsky, Milos // Biomedical Papers of the Medical Faculty of Palacky University i;Sep2014, Vol. 158 Issue 3, p384 

    Background. There are currently limited data on whether the effect of spironolactone in patients with resistant arterial hypertension depends on age and sex. Methods. Patients with an office systolic blood pressure (BP) >140 mmHg or diastolic BP >90 mmHg, despite treatment with at least 3...

  • PIII-8. Kurnik, D.; Friedman, E. A.; Muszkat, M.; Sofowora, G. G.; Xie, H. G.; Harris, P. A.; Wood, A. J.; Stein, C. M. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP60 

    Background: Clonidine, a mixed α2-(ADRA2) and α1- (ADRA1) adrenergic receptor agonist, decreased blood pressure more in Caucasians (C) than African-Americans (AA) despite a similar decline in sympathetic activity. This difference could be explained by ethnic differences in clonidine's...

  • A Multicentre, 12-Week Study of Imidapril and Candesartan Cilexetil in Patients with Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring. Palma-Gamiz, José L.; Pêgo, Mariano; Marquez, Emilio; Pujol, Montserrat; Olivan, Josefina; Alegría, Eduardo; Sagastagoitia-Gorostiza, José Domingo; Gonzalez-Juanatey, José Ramón // Clinical Drug Investigation;2007, Vol. 27 Issue 6, p407 

    BACKGROUND: Twenty-four-hour ambulatory blood pressure monitoring (ABPM) provides the most accurate efficacy assessment of an antihypertensive agent throughout a 24-hour dosing interval. The objective of this prospective, randomised, double-blind, parallel-group, multicentre study was to...

  • Clinicians Remain Reluctant to Allow Negative Findings to Influence Practice. Mitka, Mitka // JAMA: Journal of the American Medical Association;10/3/2012, Vol. 308 Issue 13, p1305 

    The article presents highlights on negative findings in clinical practices. It reflects review by the Cochrane Collaboration that questions the current guidelines in the U.S. and Europe for medical therapy which says that if there is change lifestyle then individual's blood pressure cannot be...

  • Second stroke risk is cut 65% by combined therapy. Tanday, Sanjay // GP: General Practitioner;5/1/2009, p8 

    The article reports on the result of the study which assesses the role played by second stroke risk factors in the prevention of the disease. The study was participated by 4,731 patients suffering from stroke where they were administered with atorvastation or placebo. The study found that...

  • Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. Arima, Hisatomi; Anderson, Craig; Omae, Teruo; Woodward, Mark; MacMahon, Stephen; Mancia, Giuseppe; Bousser, Marie-Germaine; Tzourio, Christophe; Harrap, Stephen; Lisheng Liu; Neal, Bruce; Chalmers, John // Journal of Neurology, Neurosurgery & Psychiatry;Nov2014, Vol. 85 Issue 11, p1284 

    Objective: There is ongoing controversy regarding a 'J-curve' phenomenon such that low and high blood pressure (BP) levels are associated with increased risks of recurrent stroke. We aimed to determine whether large treatment-related BP reductions are associated with increased risks of recurrent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics